Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: Preliminary results

European Radiology

Volumn 21, Issue 9, 2011, Pages 1970-1978

  Akin, Oguz ^a   Gultekin, David H ^a   Vargas, Hebert Alberto ^a   Zheng, Junting ^a   Moskowitz, Chaya ^a   Pei, Xin ^a   Sperling, Dahlia ^a   Schwartz, Lawrence H ^b   Hricak, Hedvig ^a   Zelefsky, Michael J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Diffusion weighted MRI; Dynamic contrast enhanced MRI; Functional imaging; MRI; Prostate

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; BIOPSY, NEEDLE; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; EVALUATION STUDIES AS TOPIC; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATIC NEOPLASMS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 80052692052     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2130-6     Document Type: Article

References (26)

1. DA Kuban HD Thames LB Levy EM Horwitz PA Kupelian AA Martinez JM Michalski TM Pisansky HM Sandler WU Shipley MJ Zelefsky AL Zietman 2003 Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era Int J Radiat Oncol Biol Phys 57 915 928 14575822 10.1016/S0360-3016(03)00632-1 (Pubitemid 37324109)
2. AL Zietman ML DeSilvio JD Slater CJ Rossi Jr DW Miller JA Adams WU Shipley 2005 Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial JAMA 294 1233 1239 16160131 10.1001/jama.294.10.1233 1:CAS:528:DC%2BD2MXpvFKhtLw%3D (Pubitemid 41352111)
3. M Roach 3rd G Hanks H Thames Jr P Schellhammer WU Shipley GH Sokol H Sandler 2006 Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 965 974 16798415 10.1016/j.ijrobp.2006.04.029
4. JW Denham M Kumar PS Gleeson DS Lamb D Joseph C Atkinson J Matthews KH Tai NA Spry D Christie S Turner PB Greer C D'Este A Steigler 2009 Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer Int J Radiat Oncol Biol Phys 74 404 411 19176272 10.1016/j.ijrobp.2008.08.047
5. T Pickles British Columbia Cancer Agency Prostate Cohort Outcomes Initiative 2006 Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy Int J Radiat Oncol Biol Phys 64 1355 1359 16406391 10.1016/j.ijrobp.2005.10.008
6. L Boccon-Gibod WB Djavan P Hammerer W Hoeltl MW Kattan T Prayer-Galetti P Teillac UW Tunn 2004 Management of prostate-specific antigen relapse in prostate cancer: a European Consensus Int J Clin Pract 58 382 390 15161124 10.1111/j.1368-5031.2004.00184.x 1:STN:280:DC%2BD2c3mt1Whug%3D%3D (Pubitemid 38714445)
7. AJ Stephenson PT Scardino FJ Bianco Jr JA Eastham 2004 Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy Curr Treat Options Oncol 5 357 365 15341674 10.1007/s11864-004-0026-2 (Pubitemid 39481238)
8. O Akin H Hricak 2007 Imaging of prostate cancer Radiol Clin North Am 45 207 222 17157630 10.1016/j.rcl.2006.10.008 (Pubitemid 44854046)
9. M Fuchsjäger O Akin A Shukla-Dave D Pucar H Hricak 2009 The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer Clin Adv Hematol Oncol 7 193 202 19398944
10. E Sala SC Eberhardt O Akin CS Moskowitz CN Onyebuchi K Kuroiwa N Ishill MJ Zelefsky JA Eastham H Hricak 2006 Endorectal MR imaging before salvage prostatectomy: tumor localization and staging Radiology 238 176 183 16373766 10.1148/radiol.2381052345 (Pubitemid 43010594)
11. FV Coakley HS Teh A Qayyum MG Swanson Y Lu M Roach 3rd B Pickett K Shinohara DB Vigneron J Kurhanewicz 2004 Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience Radiology 233 441 448 15375223 10.1148/radiol.2332032086 (Pubitemid 39423803)
12. D Pucar A Shukla-Dave H Hricak CS Moskowitz K Kuroiwa S Olgac LE Ebora PT Scardino JA Koutcher KL Zakian 2005 Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience Radiology 236 545 553 15972335 10.1148/radiol.2362040739 (Pubitemid 41023438)
13. CK Kim BK Park HM Lee 2009 Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI J Magn Reson Imaging 29 391 397 19161194 10.1002/jmri.21645
14. O Rouvière O Valette S Grivolat C Colin-Pangaud R Bouvier JY Chapelon A Gelet D Lyonnet 2004 Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor-correlation with biopsy findings Urology 63 922 927 15134982 10.1016/j.urology.2003.12.017 (Pubitemid 38596680)
15. MA Haider P Chung J Sweet A Toi K Jhaveri C Ménard P Warde J Trachtenberg G Lockwood M Milosevic 2008 Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy Int J Radiat Oncol Biol Phys 70 425 430 17881141 10.1016/j.ijrobp.2007.06.029
16. J Kurhanewicz D Vigneron P Carroll F Coakley 2008 Multiparametric magnetic resonance imaging in prostate cancer: present and future Curr Opin Urol 18 71 77 18090494 10.1097/MOU.0b013e3282f19d01 (Pubitemid 350307535)
17. AR Padhani G Liu DM Koh TL Chenevert HC Thoeny T Takahara A Dzik-Jurasz BD Ross M Van Cauteren D Collins DA Hammoud GJ Rustin B Taouli PL Choyke 2009 Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 102 125 19186405 1:CAS:528:DC%2BD1MXhvVOls70%3D
18. PS Tofts G Brix DL Buckley JL Evelhoch E Henderson MV Knopp HB Larsson TY Lee NA Mayr GJ Parker RE Port J Taylor RM Weisskoff 1999 Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusible tracer: standardized quantities and symbols J Magn Reson Imaging 10 223 232 10508281 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S 1:STN:280:DyaK1Mvjsl2jtw%3D%3D (Pubitemid 29463104)
19. ER DeLong DM DeLong DL Clarke-Pearson 1988 Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 837 845 3203132 10.2307/2531595 1:STN:280: DyaL1M%2Fns12ksQ%3D%3D
20. NA Obuchowski 1997 Nonparametric analysis of clustered ROC curve data Biometrics 53 567 578 9192452 10.2307/2533958 1:STN:280:DyaK2szjsFOrtA%3D%3D (Pubitemid 27262219)
21. AE Wefer H Hricak DB Vigneron, et al. 2000 Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology J Urol 164 400 404 10893595 10.1016/S0022-5347(05)67370-3 1:STN:280:DC%2BD3cvivF2rsQ%3D%3D (Pubitemid 30481935)
22. JD Cox MJ Gallagher EH Hammond RS Kaplan PF Schellhammer 1999 Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel J Clin Oncol 17 1155 10561174 1:STN:280:DC%2BD3c%2FivF2jsQ%3D%3D
23. J Crook S Malone G Perry Y Bahadur S Robertson M Abdolell 2000 Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients Int J Radiat Oncol Biol Phys 48 355 367 10974448 1:STN:280: DC%2BD3cvlvVCjsg%3D%3D
24. B Park B Kim C Kim H Lee G Kwon 2007 Comparison of phased-array 3.0-T and endorectal 1.5-T magnetic resonance imaging in the evaluation of local staging accuracy for prostate cancer J Comput Assist Tomogr 31 534 538 17882027 10.1097/01.rct.0000250108.85799.e1 (Pubitemid 47457665)
25. M Kimura V Mouraviev M Tsivian JM Mayes T Satoh TJ Polascik 2010 Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy BJU Int 105 191 201 19583717 10.1111/j.1464-410X.2009.08715.x 1:CAS:528:DC%2BC3cXhvFWqu7c%3D
26. MJ Zelefsky JA Eastham AM Cronin Z Fuks Z Zhang Y Yamada A Vickers PT Scardino 2010 Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix J Clin Oncol 28 1508 1513 20159826 10.1200/JCO.2009.22.2265